stocktive logo
United States ▻ Healthcare
Laboratory Corporation of America
NYSE:LH
Tea Leaves Summary
Laboratory Corporation of America [NYSE:LH] share price
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Quick Section Links
→ Sentiment
sentiment score
→ Positions
positions score
→ Growth
growth score
→ Value
value score
→ Health
health score
→ Earth
earth score
Page Updated: Aug 20, 2019

Laboratory Corporation of America [NYSE:LH] share price, stock quote Analysis

What has the stock performance of Laboratory Corporation of America been like?
stock quote price chart

Laboratory Corporation of America's (NYSE:LH) share price is 4.3% lower in the past 12 months and has underperformed the overall US TECH market which is 3.9% higher in the same timeframe. This means a -8.2% lower return over the period which puts the share price as an underperformer vs other US TECH companies.

Sentiment

Tea Leaves Score
sentiment tea score

Analyst RatingS

What are analyst ratings for Laboratory Corporation of America?
Analyst Ratings
Analyst Ratings Change
analyst ratings

From 19 analysts that cover Laboratory Corporation of America's stock, the average rating is 3.8. This is a weighted average of 3 strong buys, 10 buys, 6 holds. This is 0.1 higher than a month ago which gives this factor a tea-score of 4/5.

Positions

Tea Leaves Score
positions tea score

Insider Trades

What has Laboratory Corporation of America's insider trading been over the past year?
Sold
Bought
insider trading chart

Laboratory Corporation of America insider's have net been buying stock over the past 12 months, in the previous month insiders have been net buying. In fact the buy to sell ratio in the past month has been 50.0% which is 386.0% lower than the last 12 months buy to sell ratio. This put's Laboratory Corporation of America's Insiders in the top quintile vs their peers giving this factor a tea-score of 1/5.

Ownership

What is the ownership of Laboratory Corporation of America stock?
ownership chart

For Laboratory Corporation of America, currently 94.1% of stock (1 billion shares) is owned by Institutions, 5.3% (802 million shares) is owned by Individuals, and 0.6% (2 million shares) is owned by company insiders. The CEO has a holding of 0.02% which is equivalent to 40 thousand shares with a market value of $129 million. This factor has a tea-score of 2/5.

Short Interest

What is the short interest for Laboratory Corporation of America stock?
short interest chart

As of 31 July 2019, the short interest for Laboratory Corporation of America has been 1.70% of the shares outstanding which is 16 billion shares. This is less than 1 month ago which had 1.73% of the shares outstanding which is 17 billion short interest in shares. This equals a tea-score of 4/5.

Growth

Tea Leaves Score
growth tea leaves

Revenue & Earnings

What has Laboratory Corporation of America's revenue history been by year?
revenue chart

Laboratory Corporation of America's revenue in the last 12 months ending 30 June 2019 is $11Bn. Laboratory Corporation of America's average revenue growth for the last 4 years has been 5.1% which is currently lower than their comps of 6.2%.

Free Cash Flow Yield Growth

What is Laboratory Corporation of America's free cash flow yield?
free cash flow yield chart

Laboratory Corporation of America's free cash flow yield is 7.4% and has grown from 4 years ago. The free cash flow yield for Laboratory Corporation of America 1 year ago was 7.5% and 3 years ago it was 6.0%.

Dividend History & yield

What has Laboratory Corporation of America's dividend payments been historically?
Dividend ($)
Dividend Yield (%)
dividend chart

Laboratory Corporation of America hasn't paid any dividends for the past 4 years.

Value

Tea Leaves Score
value tea leaves

PE Ratio

What is Laboratory Corporation of America's PE ratio?
pe ratio

Laboratory Corporation of America's PE ratio is 19.6x. This is calculated from their EPS of $2.02 and price per share of $166.15. Laboratory Corporation of America's PE ratio values the company cheaper than 20% of it's competitors giving this factor a tea-score of 1/5.

PEG Ratio

What is Laboratory Corporation of America's PEG ratio?
peg ratio

Laboratory Corporation of America's PEG ratio is nanx. This is calculated from their PE ratio of 19.6x and their last 12 months growth rate of -0.186%. This is less attractive than their competitors so the tea-score for this factor is nan/5.

Share Price / Book (PB Ratio)

What is Laboratory Corporation of America's PB ratio?
PB ratio

The PB ratio for Laboratory Corporation of America is 2.3x. This is cheaper than their competitors who have an average PB ratio of 5.6x. The tea-score is 1/5.

Free Cash Flow Yield

What is Laboratory Corporation of America's free cash flow yield?
free cash flow yield

Laboratory Corporation of America's free cash flow yield is 7.4% which is ranked 1.0/5 when compared to its competitors. This is calculated from a free cash flow of $1Bn (as reported for the 12 months ending 30 June 2019) divided by its current market capitalisation of $16Bn. The average free cash flow yield across Laboratory Corporation of America's comps is 8.1%.

Return On Investment (ROI)

What is Laboratory Corporation of America's return on investment (ROI)?
return on investment

Laboratory Corporation of America's return on investment is 12.0%. This is less profitable than its competitors.

Health

Tea Leaves Score
health tea leaves

Assets vs Liabilities

What is Laboratory Corporation of America's current ratio (assets vs liabilities)?
assets vs liabilities

Laboratory Corporation of America's current ratio is calculated by (current assets) / (current liabilities) which equals 1.1x. This less attractive than their competitors and also worse than recommended for a healthy company.

Debt vs Equity

What is Laboratory Corporation of America's debt vs shareholder equity?
debt vs equity

Laboratory Corporation of America's debt to shareholder equity is 104.8%. This is worse than their competitors and also worse than advised for a well-managed balance sheet.

Dividend Payout Ratio

What is Laboratory Corporation of America's dividend payout ratio?
dividend payout ratio

-

Earth

Tea Leaves Score
ESG score
What is the overall ESG (environmental, social and corporate governance) rating for Laboratory Corporation of America?

Laboratory Corporation of America's has a poor overall ESG rating of 50/100. Their competitors have a score between 41 and 81 with the average at 59.

ESG Environmental

What the latest (ESG) environmental responsibility score for Laboratory Corporation of America vs their competitors?
ESG environmental
We can see here what the environmental consciousness of Laboratory Corporation of America is relative to other similar companies.

ESG Social

What the present (ESG) social responsibility score for Laboratory Corporation of America vs their peers?
ESG social
We can get a sense of what the social responsbility of Laboratory Corporation of America is when compared to other rival companies.

ESG Corporate Governance

What the current (ESG) corporate governance score for Laboratory Corporation of America vs their challengers?
ESG corporate governance
With this number we can understand what the corporate governance of Laboratory Corporation of America is when compared to it's peers.

APPLE [NASDAQ:AAPL] COMPANY PROFILE

Description

What is the company description of Laboratory Corporation of America?
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

Laboratory Corporation of America [NYSE:LH] Additional Q&A

Questions & Answers

What is the 52 week high for Laboratory Corporation of America stock quote?

Laboratory Corporation of America (NYSE:LH) hit a new 52-week high on 24 July 2019 at a price of $178.1 with 693,500 shares traded that day. This is 7.2% higher than than its current price of $166.15 and 47.4% higher than the 52-week low of $120.82 on 24 December 2018. Average daily volume traded has been 703 thousand shares over the past 3 months.

What is the highest price Laboratory Corporation of America stock has ever been?

The all-time highs for Laboratory Corporation of America stock were reached on 24 July 2019, 26 days ago at a price of $178.1. This equates to a market capitalisation of $17Bn. The highest price reached is 7.2% higher than the current price of $166.15 with a current market cap of $16Bn.

What is the beta of Laboratory Corporation of America stock?

Laboratory Corporation of America stock moves 1.0x the US TECH market average which makes its beta higher than the overall market.

What is the volatility of Laboratory Corporation of America (LH) stock?

Laboratory Corporation of America's stock has an annual volatility of 25.1% which is more volatile than the average US TECH market volatility of 16.3% which has made it a less safe stock to own in the past vs just owning the index for investors aiming for lower portfolio volatility.

What have Laboratory Corporation of America's share buybacks been over the past year?

Laboratory Corporation of America is currently running a share-buyback program and in the past year alone the company has repurchased 104 million of shares outstanding at a total expense of $23Trn. In the same time frame the share price has moved 4.3% lower which is an underperformance of -8.2% vs the overall market. Laboratory Corporation of America still has $420Trn of cash remaining on their balance sheet.

Who owns the most Laboratory Corporation of America stock?

Barry White is the largest individual shareholder in Laboratory Corporation of America with 1 billion shares. He is an independent director of Laboratory Corporation of America. The largest institutional holder is T-Rowe and they own 101.5% of the issue size with 100 million shares. T-Rowe have been net buying shares over the last 12 months as they own 1 million more shares than a year ago.

When did Laboratory Corporation of America beat earnings expectations in the last 4 years?

In the past 4 quarters Laboratory Corporation of America has had 3 earnings beat's and 1 earnings miss's. The average earnings beat has been 12.1% and the average earnings miss has been 8.2%.

When is Laboratory Corporation of America's next earnings date and what are the expectations?

Laboratory Corporation of America is set to report earnings on 30 July 2019 after market close. The report will be for the fiscal Quarter ending June 2019. Based on 14 analysts' forecasts, the consensus EPS forecast for the quarter is $2.12. Recent analyst revisions have been positive implying a potential EPS of $2.24.

What is Laboratory Corporation of America's upcoming earnings report expectations?

The earnings expectations for Laboratory Corporation of America's upcoming report on 30 July 2019 are from 14 analysts with an average EPS of $2.12. The lowest analyst rating is $2.01, the highest is $2.84. The most recent earnings revisions have been positive with a most recent estimate of $2.24.

What is Laboratory Corporation of America's earnings per share (EPS)?

Laboratory Corporation of America's latest earnings per share (EPS) was reported as $2.02 on 30 April 2019 for fiscal quarter ending March 2019. This is 11.0% higher than 12 months ago when they reported EPS of $1.82

What is Laboratory Corporation of America's dividend growth rate?

-

What is Laboratory Corporation of America's dividend yield?

-

What is Laboratory Corporation of America's previous and next dividend date?

-

By using this website, you accept our Terms of Use and Privacy Policy. Stocktive is not a registered investment advisory service and the information presented on this site is not intended for investment purposes. You can find out more about the team that built Stocktive on our team page. If you'd like investment advisory services we have an investment partner. Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities. Past performance is no guarantee of future results. Any historical returns, expected returns or probability projections are hypothetical in nature and may not reflect actual future performance. The analysis presented herein, the stock price, and anything related are for illustrative purposes only and are not investment recommendations. If you'd like further information about fundamental analysis you can check out a detailed wiki page.
© 2019 StockForecast
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.